Lainie Jones Comprehensive Cancer Survivorship Act of 2026
HB8839, titled the Lainie Jones Comprehensive Cancer Survivorship Act of 2026, is a broad federal cancer survivorship bill designed to improve care from the time of diagnosis through long-term follow-up. It defines survivorship expansively and directs the Department of Health and Human Services, the Department of Labor, and the National Cancer Institute to build a more coordinated survivorship system. The bill would require Medicare coverage for cancer care planning and coordination services, including individualized treatment plans and survivorship care plans, and it would direct HHS to develop an alternative payment model for survivorship care under Medicare and Medicaid.
The bill also creates several new federal initiatives: a stakeholder meeting and published resources on survivorship transition tools, a grant program for comprehensive survivorship quality-of-life services, an employment assistance program for survivors facing work-related barriers, and a GAO study on the historical progress of survivorship care. In addition, it would require Medicaid and CHIP coverage for healthcare transitions for childhood and adolescent cancer survivors and for cancer fertility services, including fertility preservation and certain storage costs, with no cost-sharing in many cases. Finally, it would establish an Office of Cancer Survivorship within the National Cancer Institute to lead research, education, and outreach on survivorship issues.
The bill would amend the Social Security Act to add new Medicare, Medicaid, and CHIP benefits and to prohibit cost-sharing for certain fertility-related services. It would also create new federal administrative responsibilities for HHS, Labor, GAO, and NCI, including payment-model development, grantmaking, reporting, stakeholder engagement, and publication of survivorship guidance. If enacted, it would expand access to survivorship planning, transition care, fertility preservation, and supportive services for cancer survivors, while also affecting providers, payors, state Medicaid programs, and community organizations that deliver cancer-related services.
No committee transcripts or recorded votes were provided, and the bill has only been referred to committee. Based on the text, the measure appears strongly supportive of cancer survivors and their families, with a focus on improving quality of life, care coordination, and long-term outcomes. The bipartisan list of original cosponsors suggests at least some cross-party interest in the issue, but there is no direct evidence in the provided materials of formal support or opposition during debate.
The most likely points of contention are the bill’s cost and administrative scope, especially the new Medicare and Medicaid coverage mandates, the no-cost-sharing fertility provisions, and the creation of new federal programs and an NCI office. Another possible area of debate is federal-state responsibility, since the bill would require state Medicaid and CHIP coverage for specific survivorship and fertility services. The bill also raises implementation questions about defining survivorship care, setting payment rates, determining episode lengths in the alternative payment model, and ensuring privacy and security for digital survivorship tools.